LOX and glioblastoma: The results showed that LOX inhibition genetically (e.g., shRNA-mediated LOX depletion) and pharmacologically (treatment with LOX inhibitor BAPN) upregulated the expression of PD-L1 in PTEN-deficient GBM cells (Figure 1, G–J and Supplemental Figure 1, J–L).